Role of Glucuronidation for Hepatic Detoxification and Urinary Elimination of Toxic Bile Acids during Biliary Obstruction

• Martin Perreault,

  Affiliation Laboratory of molecular pharmacology, CHU-Québec Research Centre and the Faculty of Pharmacy, Laval University, Québec, Canada

  ⨯
• Andrzej Białek,

  Affiliation Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland

  ⨯
• Jocelyn Trottier,

  Affiliation Laboratory of molecular pharmacology, CHU-Québec Research Centre and the Faculty of Pharmacy, Laval University, Québec, Canada

  ⨯
• Mélanie Verreault,

  Affiliation Laboratory of molecular pharmacology, CHU-Québec Research Centre and the Faculty of Pharmacy, Laval University, Québec, Canada

  ⨯
• Patrick Caron,

  Affiliation Laboratory of molecular pharmacology, CHU-Québec Research Centre and the Faculty of Pharmacy, Laval University, Québec, Canada

  ⨯
• Piotr Milkiewicz,

  Affiliations Liver Research Laboratories, Pomeranian Medical University, Szczecin, Poland, Liver Unit, Department of Surgery and Liver Transplantation, Warsaw Medical University, Warsaw, Poland

  ⨯
• Olivier Barbier

  * E-mail: olivier.barbier@crchul.ulaval.ca

  Affiliation Laboratory of molecular pharmacology, CHU-Québec Research Centre and the Faculty of Pharmacy, Laval University, Québec, Canada

  ⨯